Comparison of the Incidence and Pattern of Interstitial Lung Disease During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer: The Okayama Lung Cancer Study Group Experience

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3181ca12e0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

ILD During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Successful Treatment of Non-Small Cell Lung Cancer With Gefitinib After Severe Erlotinib-Related Hepatotoxicity

Internal Medicine
Internal MedicineMedicine
2012English

Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study

Oncology Letters
Cancer ResearchOncology
2010English

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients With Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy

Journal of Cancer
Oncology
2018English

Observational Study on the Efficacy and Safety of Erlotinib in Patients With Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2012English

Management of Patients With Advanced Non-Small Cell Lung Cancer: Role of Gefitinib

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2010English

Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy